Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
4.
Prog Urol ; 25(17): 1204-12, 2015 Dec.
Article in French | MEDLINE | ID: mdl-26149176

ABSTRACT

INTRODUCTION: The aim of this study was to assess efficacy, complication and feasibility of outpatient suburethral slings for stress urinary incontinence in women. MATERIAL AND METHODS: A systematic review of the literature was done from the Pubmed data-base by searching following keywords: suburethral sling, midurethral sling, TVT, TOT, outpatient surgery, day surgery. RESULTS: Seventy-eight percent to 88% of patients were continent postoperatively, and 6.8 to 12% of patients were significantly improved. No major complication occurred and minor complications were observed in 7.2 to 19.8% of patients. Eighty to 86.6% of patients experienced no complication. Seventy percent to 100% of patients were discharged on post operative day 0. The satisfaction rate was 89.4 to 95%. CONCLUSION: Outpatient suburethral sling for stress urinary incontinence is suitable, effective, with a low complication rate, and with a high rate of satisfaction.


Subject(s)
Ambulatory Surgical Procedures , Suburethral Slings , Urinary Incontinence, Stress/surgery , Female , Humans , Suburethral Slings/adverse effects , Treatment Outcome , Urologic Surgical Procedures
6.
Curr Top Microbiol Immunol ; 314: 293-323, 2007.
Article in English | MEDLINE | ID: mdl-17593666

ABSTRACT

CD1d-restricted T cells (NKT cells) are potent regulators of a broad range of immune responses. In particular, an abundance of research has focussed on the role of NKT cells in tumor immunity. This field of research has been greatly facilitated by the finding of agonist ligands capable of potently stimulating NKT cells and also animal models where NKT cells have been shown to play a natural role in the surveillance of tumors. Herein, we review the capability of NKT cells to promote the rejection of tumors and the mechanisms by which this occurs. We also highlight a growing field of research that has found that NKT cells are capable of suppressing anti-tumor immunity and discuss the progress to date for the immunotherapeutic use of NKT cells.


Subject(s)
Antigens, CD1/metabolism , Killer Cells, Natural/immunology , Neoplasms/immunology , Animals , Clinical Trials, Phase I as Topic , Disease Models, Animal , Galactosylceramides/immunology , Galactosylceramides/therapeutic use , Humans , Killer Cells, Natural/metabolism , Mice , Monitoring, Immunologic , Neoplasms/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...